GK Couto, NV Segatto, TL Oliveira, FK Seixas… - Frontiers in …, 2019 - frontiersin.org
The global incidence of cancer is rising rapidly and continues to be one of the leading causes of death in the world. Melanoma deserves special attention since it represents one of …
M Sun, Y Zhang, J Qin, M Ba, Y Yao, Y Duan, H Liu… - Bioorganic …, 2021 - Elsevier
Here, we report the structural optimization of a hit natural compound, 2-ME 2 (2- methoxyestradiol), which exhibited inhibitory activity but low potency on tubulin …
The process of creating a series of 3-amino-1-aryl-8-methoxy-1 H-benzo [f] chromene-2- carbonitriles (4a-q) involved reacting 6-methoxynaphthalen-2-ol (1), the appropriate …
H Yang, D Zhang, Z Yuan, H Qiao, Z Xia, F Cao… - European Journal of …, 2024 - Elsevier
In this study, a series of novel 4-Aryl-4H-chromene derivatives (D1-D31) were designed and synthesized by integrating quinoline heterocycle to crolibulin template molecule based on …
KL Adeleye, AR Li, Y Xie… - Journal of Dental …, 2024 - journals.sagepub.com
Effective management of head and neck cancer (HNC) poses a significant challenge in the field of oncology, due to its intricate pathophysiology and limited treatment options. The most …
H Wang, C Nie, M Luo, Q Bai, Z Yao, H Lv, B Chen… - Bioorganic …, 2024 - Elsevier
Antineoplastic agents that target tubulin have shown efficacy as chemotherapeutic drugs, yet they are often constrained by multidrug resistance (MDR) and unwanted side effects. A multi …
Y Shan, R Si, J Wang, Q Zhang, H Zhou, J Song… - European Journal of …, 2019 - Elsevier
Aberrant angiogenesis is a hallmark of various diseases including cancers. VEGFR-2 inhibitors have been utilized as anti-angiogenic agents for several years. However …
H Zhang, XQ Zhang, LS Huang, X Fang, M Khan… - … and Biophysics Reports, 2022 - Elsevier
Even though substantial progress has been made in the treatment of hepatitis C virus (HCV) infection, viral resistance and relapse still occur in some patients and additional therapeutic …